When AIS occurs, the level of IL-6 in the patient's body increases rapidly in a short period of time, and the prognosis of AIS after 3 months is poor due to elevated level of inflammation, mainly in terms of the modified Rankin Scale (mRS), National Institute of Health Stroke Scale (NIHSS), and increased mortality. This evidence concerns the gene IL6 and Stroke.